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AIMS: Oxidants have been implicated in the pathophysiology of idiopathic pulmonary
fibrosis (IPF), especially in myofibroblastic differentiation. We aimed at testing the
hypothesis that nuclear factor erythroid 2-related factor 2 (Nrf2), the main regulator
of endogenous antioxidant enzymes, is involved in fibrogenesis via myofibroblastic
differentiation. Fibroblasts were cultured from the lungs of eight controls and eight
IPF patients. Oxidants-antioxidants balance, nuclear Nrf2 expression, and fibroblast
phenotype (α-smooth muscle actin and collagen I expression, proliferation,
migration, and contraction) were studied under basal conditions and after Nrf2
knockdown or activation by Nrf2 or Keap1 siRNA transfection. The effects of
sulforaphane (SFN), an Nrf2 activator, on the fibroblast phenotype were tested
under basal and pro-fibrosis conditions (transforming growth factor β [TGF-β]).
RESULTS: Decreased Nrf2 expression was associated with a myofibroblast
phenotype in IPF compared with control fibroblasts. Nrf2 knockdown induced
oxidative stress and myofibroblastic differentiation in control fibroblasts. Conversely,
Nrf2 activation increased antioxidant defences and myofibroblastic dedifferentation
in IPF fibroblasts. SFN treatment decreased oxidants, and induced Nrf2 expression,
antioxidants, and myofibroblastic dedifferentiation in IPF fibroblasts. SFN inhibited
TGF-β profibrotic deleterious effects in IPF and control fibroblasts and restored
antioxidant defences. Nrf2 knockdown abolished SFN antifibrosis effects, suggesting
that they were Nrf2 mediated.
INNOVATION AND CONCLUSION: Our findings confirm that decreased nuclear
Nrf2 plays a role in myofibroblastic differentiation and that SFN induces human
pulmonary fibroblast dedifferentiation in vitro via Nrf2 activation. Thus, Nrf2 could
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